ETH researchers have developed a new gene switch that can be activated using a commercially available nitroglycerine patch ...
Nitroglycerin 0.1mg/hr, 0.2mg/hr, 0.3mg/hr, 0.4mg/hr, 0.6mg/hr, 0.8mg/hr; transdermal patches. The principal pharmacological action is relaxation of vascular smooth muscle and consequent ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果